Status:
UNKNOWN
Therapeutic Effect of an Herbal Medicine on Anxiety
Lead Sponsor:
Millet Roux
Conditions:
Anxiety Disorders
Eligibility:
All Genders
18-65 years
Phase:
PHASE3
Brief Summary
Phase III, double blind, randomized study, controlled by Valeriana officinalis L for evaluating the efficacy of association of Passiflora incarnata L; Crataegus Oxyacantha L and Salix alba L. in gener...
Detailed Description
The main objective of this study is to evaluate the clinical efficacy of the drug Passiflorine® (Passiflora incarnata L; Crataegus Oxyacantha L and Salix alba L) compared to Valeriana officinalis over...
Eligibility Criteria
Inclusion
- Clinical diagnosis of generalized anxiety disorder
- HAM-A scale \> 17 and \<30
Exclusion
- HAM-A scale \> 30
- Psychotherapy
Key Trial Info
Start Date :
October 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2012
Estimated Enrollment :
136 Patients enrolled
Trial Details
Trial ID
NCT01178632
Start Date
October 1 2010
End Date
July 1 2012
Last Update
August 10 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Clinical Pharmacology Unit - Unifac
Fortaleza, Ceará, Brazil, 60430-270